Related Experiment Video
Updated: Mar 19, 2026
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Cheminformatics Based Machine Learning Approaches for Assessing Glycolytic Pathway Antagonists of Mycobacterium
Kanupriya Tiwari, Salma Jamal, Sonam Grover
1School of Biotechnology, Jawaharlal Nehru University, New Delhi, India -110067. agrover@jnu.ac.in.
Background:
Tuberculosis is the second leading cause of death from an infectious disease worldwide after HIV, thus reasoning the expeditions in antituberculosis research. The rising number of cases of infection by resistant forms of M. tuberculosis has given impetus to the development of novel drugs that have different targets and mechanisms of action against the bacterium.
Methods:
In this study, we have used machine learning algorithms on the available high throughput screening data of inhibitors of fructose bisphosphate aldolase, an enzyme central to the glycolysis pathway in M. tuberculosis, to build predictive classification models to identify actives against Mycobacterium tuberculosis, the causative organism of tuberculosis. We used Naïve Bayes, Random Forest and C4.5 J48 algorithms available from Weka were used for building predictive classification models. Additionally, a set of most relevant attributes was selected using genetic search algorithm which offered improved model performance by avoiding over fitting and generating faster and cost effective models.
Results:
The model built using machine learning methods in this study provided good accuracy of classification of test compounds which suggests that in silico methods can be successfully used for screening of large datasets to identify potential drug leads. The substructure fragment analysis serves to further potentiate the M. tuberculosis drug development process as it would facilitate identification of structural fragments that are responsible for biological activity against this crucial glycolysis pathway target.
Insights
Machine learning models accurately identify potential tuberculosis drugs by analyzing enzyme inhibitors. This approach accelerates the discovery of new treatments targeting Mycobacterium tuberculosis.
Area of Science:
- Computational chemistry
- Drug discovery
- Machine learning in pharmacology
Background:
- Tuberculosis (TB) remains a leading infectious disease killer globally.
- Rising drug-resistant Mycobacterium tuberculosis strains necessitate novel therapeutic strategies.
- Targeting essential bacterial enzymes, like fructose bisphosphate aldolase, is a key research area.
Purpose of the Study:
- To develop predictive classification models for identifying active compounds against Mycobacterium tuberculosis.
- To leverage machine learning on high-throughput screening data for drug lead identification.
- To explore the utility of in silico methods in accelerating TB drug development.
Main Methods:
- Applied machine learning algorithms (Naïve Bayes, Random Forest, C4.5 J48) to high-throughput screening data.
- Utilized a genetic search algorithm for selecting relevant attributes to improve model performance and efficiency.
- Focused on inhibitors of fructose bisphosphate aldolase, a critical enzyme in M. tuberculosis glycolysis.
Main Results:
- Machine learning models achieved high accuracy in classifying test compounds.
- In silico screening of large datasets proved effective for identifying potential drug leads.
- Substructure fragment analysis identified key structural components responsible for biological activity.
Conclusions:
- Machine learning offers a powerful and efficient approach for tuberculosis drug discovery.
- In silico methods can significantly accelerate the identification of novel anti-TB agents.
- Understanding structure-activity relationships aids in developing targeted therapies against M. tuberculosis.
More Related Videos
15:28A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
Published on: January 17, 2014
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
